Suppression of experimental immune-mediated blepharoconjunctivitis in Brown Norxway rats by topical application of FK506

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 2, 2002, Pages 137-143

  Nishino, Koji ^a   Fukushima, Atsuki ^a   Okamoto, Shigeki ^b   Ohashi, Yuichi ^b   Fukata, Kazuyo ^a   Ozaki, Akemi ^a   Ueno, Hiasyuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DRUG VEHICLE; EYE DROPS; IMMUNOGLOBULIN E; INTERLEUKIN 4; OVALBUMIN; TACROLIMUS;

ACTIVE IMMUNIZATION; ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CELL INFILTRATION; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; EOSINOPHIL; EXPERIMENTAL IMMUNE MEDIATED BLEPHAROCONJUNCTIVITIS; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPH NODE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SYSTEMIC DISEASE; T LYMPHOCYTE;

EID: 0036941252     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-001-0424-0     Document Type: Article

References (36)

1. Clipstone NA, Crabtree GR (1992) Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697
2. Doherty MJ, Easty DL (1989) Inflammatory and immunological cell profiles in a rat model of conjunctival immediate hypersensitivity. Clin Exp Allergy 19:449-455
3. Donshik PC (1988) Allergic conjunctivitis. Int Ophthalmol Clin 28:294-302
4. Durham SR (1998) Mechanisms of mucosal inflammation in nose and lungs. Clin Exp Allergy 28 Suppl 2:11-16
5. Eum SY, Zuany-Amorim C, Lefort J, Pretolani M, Vargaftig BB (1997) Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice. Br J Pharmacol 120:130-136
6. Foster CS, Calonge M (1990) Atopic keratoconjunctivitis. Ophthalmology 97:992-1000
7. Fukushima A, Yoshida H, Iwamoto H, Yoshida O, Ueno H (1997) The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivitis (EAC) in rats. Exp Eye Res 65:631-637
8. Gleich GJ (1982) The late phase of immunoglobulin E-mediated reaction: a linkbetween anaphylaxis and common allergic disease? J Allergy Clin Immunol 70:160-169
9. Goetzl EJ (1977) Mast cell-mediated reactions of host defense and tissue injury: the regulatory role of eosinophil and polymorphonuclear leukocytes. Inflammation 2:239-256
10. Goto T, Kino T, Hatanaka H, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1991) FK 506: historical perspectives. Transplant Proc 23:2713-2717
11. Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S (1998) A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology 105:1715-1720
12. Iwamoto H, Yoshida H, Yoshida O, Fukushima A, Ueno H (1999) Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical admministration. Graefe's Arch Clin Exp Ophthalmol 237:407-414
13. Iwamoto H, Nishino K, Magone TM, Whitcup SM, Yoshida O, Yoshoda H, Ozaki A, Fukushima A, Ueno H (2000) Experimental immune-mediated blepharoconjunctivitis in rats induced by immunization with ragweed pollen. Graefe's Arch Clin Exp Ophthalmol 238:346-351
14. Kitamura Y (1989) Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 7:59-76
15. Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K, Yamamoto K (1999) A potent immunosuppressant FK506 inhibits IL-8 expression in human eosinophils. Mol Cell Biol Res Commun 1:72-77
16. Li B, Toumier C, Davis RJ, Flavell RA (1999) Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J 18:420-432
17. Magone MT, Whitcup SM, Fukushima A, Chan CC, Silver PB, Rizzo LV (2000) The role of IL- 12 in the induction of late-phase cellular infiltration in a murine model in allergic conjunctivitis. J Allergy Clin Immunol 105:299-308
18. Matsuda S, Moriguchi T, Koyasu S, Nishida E (1998) T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7- SAPK/JNK signaling pathways sensitive to cyclosporin A. J Biol Chem 273:12378-12382
19. Mattila PS (1996) The actions of cyclosporin A and FK506 on T-lymphocyte activation. Biochem Soc Trans 24:45-49
20. Meng AL, Pinckard RN, Halonen M (1973) Ontogeny of the release and reactivity to mediators of IgE-induced acute allergic reactions in the rabbit: the homologous PCA reaction. J Immunol 110:1554-1561
21. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, Yamamoto K, Ito K, Tsuruoka N, Okudaira H (1995) IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Inummol 7:449-457
22. Nomura K, Takamura E (1998) Tear IgE concentrations in allergic conjunctivitis. Eye 12:296-298
23. Ozaki A, Fukushima A, Fukata K, Ueno H (2000) Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway ras. Clin Exp Immunol 122:28-34
24. Pacocha SE, Oriente A, Huang SK, Essayan DM (1999) Regulation of antigen- induced human T-lymphocyte responses by calcineurin antagonists. J Allergy Clin Immunol 104:828-835
25. Rolfe FG, Valentine JE, Sewell WA (1997) Cyclosporin A and FK506 reduce interleukin-5 mRNA abundace by inhibiting gene transcription. Am J Respir Cell Mot Biol 17:243-250
26. Rovira P, Mascarell L, Truffa-Bachi P (2000) The impact of immunosuppressive drugs on the analysis of T cell activation. Curr Med Chem 7:673-692
27. Salgado CG, Nakamura K, Sugaya M, Tada Y, Asahina A, Fukuda S, Koyama Y, Irie S, Tamaki K (1999) Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells. 1. J Invest Dermatol 113:1021-1027
28. Sano T, Nakamura Y, Matsunaga Y, Takahashi T, Azuma M, Okano Y, Shimizu E, Ogushi F, Sone S, Ogura T (1995) FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma. Eur Respir J 8:1473-1478
29. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y (1994) JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727-736
30. Takemoto N, Koyano-Nakagawa N, Arai N, Arai K, Yokota T (1997) Four P-like elements are required for optimal transcription of the mouse Il-4 gene: involvement of a distinct set of nuclear factor of activated T cells and activator protein-1 family proteins. Int Immunol 9:1329-1338
31. Trocme SD, Bonini S, Barney NP, Bloch KJ, Allansmith MR (1988) Late-phase reaction in topically induced ocular anaphylaxis in the rat. Curr Eye Res 7: 437-443
32. Tsicopoulos A, Hamid Q, Haczku A, Jacobson MR, Durham SR, North J, Barkans J, Corrigan CJ, Meng Q, Moqbel R, et al (1994) Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 94:764-772
33. Umland SP, Razac S, Shah H, Nahrebne DK, Egan RW, Billah MM (1998) Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma. Am J Respir Cell Mol Biol 18:631-642
34. Yamashita N, Koizumi H, Murata M, Mano K, Ohta K (1999) Nuclear factor kappa B mediates interleukin-8 production in eosinophils. Int Arch Allergy Immunol 120:230-236
35. Yoshida H, Yoshida O, Iwamoto H, Nishino K, Hashida M, Fukushima A, Ueno H (1998) Analysis of effects of stimulation in vitro of ovalbumin primed lymph node cells on adoptive transfer of experimental immune mediated blepharoconjunctivitis in Lewis rats. Br J Ophthalmol 82:1189-1194
36. Yoshida O, Yoshida H, Iwamoto H, Nishino K, Fukushima A, Ueno H (1999) Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res 18:117-124